Keywords
Cancer
Cancer stem cells
Health
Submitted : 2024-08-26
Accepted : 2024-09-10
Published : 2024-09-25
Abstract
Cancer stem cells (CSCs), or tumor-initiating cells (TICs), are cancerous cell subpopulations that remain while tumor cells propagate as a unique subset and exhibit multiple applications in several diseases. They are responsible for cancer cell initiation, development, metastasis, proliferation, and recurrence due to their self-renewal and differentiation abilities in many kinds of cells. Artificial intelligence (AI) has gained significant attention because of its vast applications in various fields including agriculture, healthcare, transportation, and robotics, particularly in detecting human diseases such as cancer. The division and metastasis of cancerous cells are not easy to identify at early stages due to their uncontrolled situations. It has provided some real-time pictures of cancer progression and relapse. The purpose of this review paper is to explore new investigations into the role of AI in cancer stem cell progression and metastasis and in regenerative medicines. It describes the association of machine learning and AI with CSCs along with its numerous applications from cancer diagnosis to therapy. This review has also provided key challenges and future directions of AI in cancer stem cell research diagnosis and therapeutic approach.
References
Ng DTK, Lee M, Tan RJY, et al., 2023, A Review of AI Teaching and Learning from 2000 to 2020. Educ Inf Technol, 28: 8445–8501. https://doi.org/10.1007/s10639-022-11491-w
Nozari H, Ghahremani-Nahr J, Szmelter-Jarosz A, 2024, Chapter One – AI and Machine Learning for Real-World Problems. Advances in Computer, 134: 1–12. https://doi.org/10.1016/bs.adcom.2023.02.001
Karwasra R, Sharma S, Sharma I, et al., 2024, Autoimmune Autonomic Disorder: AI-Based Diagnosis and Prognosis, in Raza K, Singh S (eds) Artificial Intelligence and Autoimmune Diseases: Application in the Diagnosis, Prognosis, and Therapeutics. Springer Nature Singapore, Singapore, 77–98. https://doi.org/10.1007/978-981-99-9029-0_4
Saini A, Kumar M, Bhatt S, et al., 2020, Cancer Causes and Treatments. Int J Pharm Sci Res, 11: 3121–3134.
Zhong L, Li Y, Xiong L, et al., 2021, Small Molecules in Targeted Cancer Therapy: Advances, Challenges, and Future Perspectives. Signal Transduct Target Ther, 6(1): 201. https://doi.org/10.1038/s41392-021-00572-w
Mani DR, Krug K, Zhang B, et al., 2022, Cancer Proteogenomics: Current Impact and Future Prospects. Nat Rev Cancer, 22(5): 298–313. https://doi.org/10.1038/s41568-022-00446-5
Cao R, Yuan L, Ma B, et al., 2020, Immune-Related Long Non-Coding RNA Signature Identified Prognosis and Immunotherapeutic Efficiency in Bladder Cancer (BLCA). Cancer Cell Int, 20: 276. https://doi.org/10.1186/s12935-020-01362-0
Xiao Y, Yu D, 2021, Tumor Microenvironment as A Therapeutic Target in Cancer. Pharmacol Ther, 221: 107753. https://doi.org/10.1016/j.pharmthera.2020.107753
DuCote TJ, Naughton KJ, Skaggs EM, et al., 2023, Using Artificial Intelligence to Identify Tumor Microenvironment Heterogeneity in Non-Small Cell Lung Cancers. Lab Invest, 103(8): 100176. https://doi.org/10.1016/j.labinv.2023.100176
Lee RY, Wu Y, Goh D, et al., 2023, Application of Artificial Intelligence to In Vitro Tumor Modeling and Characterization of the Tumor Microenvironment. Adv Healthc Mater, 12(14): e2202457. https://doi.org/10.1002/adhm.202202457
Noto JM, Piazuelo MB, Romero-Gallo J, et al., 2023, Targeting Hypoxia-Inducible Factor-1 Alpha Suppresses Helicobacter pylori-Induced Gastric Injury via Attenuation of Both Cag-Mediated Microbial Virulence and Proinflammatory Host Responses. Gut Microbes, 15(2): 2263936. https://doi.org/10.1080/19490976.2023.2263936
Sutherland TE, Dyer DP, Allen JE, 2023, The Extracellular Matrix and the Immune System: A Mutually Dependent Relationship. Science, 379(6633): eabp8964. https://doi.org/10.1126/science.abp8964
Zhang Y, Zhang Z, 2020, The History and Advances in Cancer Immunotherapy: Understanding the Characteristics of Tumor-Infiltrating Immune Cells and Their Therapeutic Implications. Cell Mol Immunol, 17(8): 807–821. https://doi.org/10.1038/s41423-020-0488-6
Downes N, Niskanen H, Tomas Bosch V, et al., 2023, Hypoxic Regulation of Hypoxia Inducible Factor 1 Alpha via Antisense Transcription. J Biol Chem, 299(11): 105291. https://doi.org/10.1016/j.jbc.2023.105291
Ribeiro Franco PI, Rodrigues AP, de Menezes LB, et al., 2020, Tumor Microenvironment Components: Allies of Cancer Progression. Pathol Res Pract, 216(1): 152729. https://doi.org/10.1016/j.prp.2019.152729
Moindjie H, Rodrigues-Ferreira S, Nahmias C, 2021, Mitochondrial Metabolism in Carcinogenesis and Cancer Therapy. Cancers (Basel), 13(13): 3311. https://doi.org/10.3390/cancers13133311
Nong S, Han X, Xiang Y, et al., 2023, Metabolic Reprogramming in Cancer: Mechanisms and Therapeutics. MedComm (2020), 4(2): e218. https://doi.org/10.1002/mco2.218
Khorasani A, Shahbazi-Gahrouei D, Safari A, 2023, Recent Metal Nanotheranostics for Cancer Diagnosis and Therapy: A Review. Diagnostics (Basel), 13(5): 833. https://doi.org/10.3390/diagnostics13050833
Awasthi R, Mishra S, Cywinski JB, et al., 2023, Quantitative and Qualitative Evaluation of the Recent Artificial Intelligence in Healthcare Publications using Deep-Learning. medRxiv, 2023. https://doi.org/10.1101/2022.12.31.22284092
Chugh V, Basu A, Kaushik A, et al., 2024, Employing Nano-Enabled Artificial Intelligence (AI)-Based Smart Technologies for Prediction, Screening, and Detection of Cancer. Nanoscale, 16(11): 5458–5486. https://doi.org/10.1039/d3nr05648a
Zhou R, Tong F, Zhang Y, et al., 2023, Genomic Alterations Associated with Pseudoprogression and Hyperprogressive Disease During Anti-PD1 Treatment for Advanced Non-Small-Cell Lung Cancer. Front Oncol, 13: 1231094. https://doi.org/10.3389/fonc.2023.1231094
Rasool S, Ali M, Shahroz HM, et al., 2024, Innovations in AI-Powered Healthcare: Transforming Cancer Treatment with Innovative Methods. BULLET: Jurnal Multidisiplin Ilmu, 3(1): 118–128.
Choudhary A, Ahlawat S, Urooj S, et al., 2023, A Deep Learning-Based Framework for Retinal Disease Classification. Healthcare (Basel), 11(2): 212. https://doi.org/10.3390/healthcare11020212
Khan SU, Jan S, Fatima K, et al., 2024, Future Directions and Challenges in Overcoming Drug Resistance in Cancer, in Khan SU, Malik F (eds) Drug Resistance in Cancer: Mechanisms and Strategies. Springer Nature Singapore, Singapore, 351–372. https://doi.org/10.1007/978-981-97-1666-1_12
Sudha B, Suganya K, Swathi K, et al., 2022, Artificial Intelligence is Revolutionizing Cancer Research, in Devi KG, Balasubramanian K, Ngoc LA (eds) Machine Learning and Deep Learning Techniques for Medical Science. CRC Press, Boca Raton (FL), 263–278.
Chen ZH, Lin L, Wu CF, et al., 2021, Artificial Intelligence for Assisting Cancer Diagnosis and Treatment in the Era of Precision Medicine. Cancer Commun (Lond), 41(11): 1100–1115. https://doi.org/10.1002/cac2.12215
Rao C, Liu Y, 2020, Three-Dimensional Convolutional Neural Network (3D-CNN) for Heterogeneous Material Homogenization. Comput Mater Sci, 184: 109850. https://doi.org/10.1016/j.commatsci.2020.109850
Luchini C, Pea A, Scarpa A, 2022, Artificial Intelligence in Oncology: Current Applications and Future Perspectives. Br J Cancer, 126(1): 4–9. https://doi.org/10.1038/s41416-021-01633-1
Wilhelm M, Zolg DP, Graber M, et al., 2021, Deep Learning Boosts Sensitivity of Mass Spectrometry-Based Immunopeptidomics. Nat Commun, 12(1): 3346. https://doi.org/10.1038/s41467-021-23713-9. Erratum in Nat Commun, 12(1): 4002. https://doi.org/10.1038/s41467-021-24263-w
Wu J, Hicks C, 2021, Breast Cancer Type Classification Using Machine Learning. J Pers Med, 11(2): 61. https://doi.org/10.3390/jpm11020061
Tran TO, Vo TH, Le NQK, 2024, Omics-Based Deep Learning Approaches for Lung Cancer Decision-Making and Therapeutics Development. Brief Funct Genomics, 23(3): 181–192. https://doi.org/10.1093/bfgp/elad031. Erratum in Brief Funct Genomics, elad046. https://doi.org/10.1093/bfgp/elad046
Sufyan M, Shokat Z, Ashfaq UA, 2023, Artificial Intelligence in Cancer Diagnosis and Therapy: Current Status and Future Perspective. Comput Biol Med, 165: 107356. https://doi.org/10.1016/j.compbiomed.2023.107356
Tan P, Chen X, Zhang H, et al., 2023, Artificial Intelligence Aids in Development of Nanomedicines for Cancer Management. Semin Cancer Biol, 89: 61–75. https://doi.org/10.1016/j.semcancer.2023.01.005
Wang C, Yu P, Zhang H, et al., 2023, Artificial Intelligence-Based Prediction of Cervical Lymph Node Metastasis in Papillary Thyroid Cancer with CT. Eur Radiol, 33(10): 6828–6840. https://doi.org/10.1007/s00330-023-09700-2
Tosca EM, Ronchi D, Facciolo D, et al., 2023, Replacement, Reduction, and Refinement of Animal Experiments in Anticancer Drug Development: The Contribution of 3D In Vitro Cancer Models in the Drug Efficacy Assessment. Biomedicines, 11(4): 1058. https://doi.org/10.3390/biomedicines11041058
Ho D, 2020, Artificial Intelligence in Cancer Therapy. Science, 367(6481): 982–983. https://doi.org/10.1126/science.aaz3023
Dandale MN, Yadav AP, Reddy PSK, et al., 2024, Deep Learning Enhanced Drug Discovery for Novel Biomaterials in Regenerative Medicine Utilizing Graph Neural Network Approach for Predicting Cellular Responses. The Scientific Temper, 15(1): 1588–1594. https://doi.org/10.58414/SCIENTIFICTEMPER.2024.15.1.04
Altyar AE, El-Sayed A, Abdeen A, et al., 2023, Future Regenerative Medicine Developments and Their Therapeutic Applications. Biomed Pharmacother, 158: 114131. https://doi.org/10.1016/j.biopha.2022.114131
Farajpour H, Banimohamad-Shotorbani B, Rafiei-Baharloo M, et al., 2024, Application of Artificial Intelligence in Regenerative Medicine. Neurosci J Shefaye Khatam, 11(4): 94–107. https://doi.org/10.61186/shefa.11.4.94
Hasselgren C, Oprea TI, 2024, Artificial Intelligence for Drug Discovery: Are We There Yet? Annu Rev Pharmacol Toxicol, 64: 527–550. https://doi.org/10.1146/annurev-pharmtox-040323-040828
Jeyaraman M, Ratna HVK, Jeyaraman N, et al., 2023, Leveraging Artificial Intelligence and Machine Learning in Regenerative Orthopedics: A Paradigm Shift in Patient Care. Cureus, 15(11): e49756. https://doi.org/10.7759/cureus.49756
Qureshi R, Irfan M, Gondal TM, et al., 2023, AI in Drug Discovery and Its Clinical Relevance. Heliyon, 9(7): e17575. https://doi.org/10.1016/j.heliyon.2023.e17575
Fan B 2023, Limitations and Ethical Implications of Artificial Intelligence, in Xia M, Jiang H (eds) Artificial Intelligence in Anesthesiology. Springer Nature Singapore, Singapore, 109–113. https://doi.org/10.1007/978-981-99-5925-9_12
Elemento O, Leslie C, Lundin J, et al., 2021, Artificial Intelligence in Cancer Research, Diagnosis and Therapy. Nat Rev Cancer, 21(12): 747–752. https://doi.org/10.1038/s41568-021-00399-1
Deus IA, Mano JF, Custodio CA, 2020, Perinatal Tissues and Cells in Tissue Engineering and Regenerative Medicine. Acta Biomater, 110: 1–14. https://doi.org/10.1016/j.actbio.2020.04.035
Alsuliman T, Humaidan D, Sliman L, 2020, Machine Learning and Artificial Intelligence in the Service of Medicine: Necessity or Potentiality? Curr Res Transl Med, 68(4): 245–251. https://doi.org/10.1016/j.retram.2020.01.002
Greenberg ZF, Graim KS, He M, 2023, Towards Artificial Intelligence-Enabled Extracellular Vesicle Precision Drug Delivery. Adv Drug Deliv Rev, 199: 114974. https://doi.org/10.1016/j.addr.2023.114974
Khan B, Fatima H, Qureshi A, et al., 2023, Drawbacks of Artificial Intelligence and Their Potential Solutions in the Healthcare Sector. Biomed Mater Devices, 2023: 1–8. https://doi.org/10.1007/s44174-023-00063-2
Abubakar M, Bukhari SMA, Mustfa W, et al., 2024, Skin Cancer and Human Papillomavirus. J Popul Ther Clin Pharmacol, 31(2): 790–816.
Chassagnon G, De Margerie-Mellon C, Vakalopoulou M, et al., 2023, Artificial Intelligence in Lung Cancer: Current Applications and Perspectives. Jpn J Radiol, 41(3): 235–244. https://doi.org/10.1007/s11604-022-01359-x
Santa-Rosario JC, Gustafson EA, Sanabria Bellassai DE, et al., 2024, Validation and Three Years of Clinical Experience in Using An Artificial Intelligence Algorithm as A Second Read System for Prostate Cancer Diagnosis-Real-World Experience. J Pathol Inform, 15: 100378. https://doi.org/10.1016/j.jpi.2024.100378
Damiani C, Kalliatakis G, Sreenivas M, et al., 2023, Evaluation of an AI Model to Assess Future Breast Cancer Risk. Radiology, 307(5): e222679. https://doi.org/10.1148/radiol.222679
Yin Z, Yao C, Zhang L, et al., 2023, Application of Artificial Intelligence in Diagnosis and Treatment of Colorectal Cancer: A Novel Prospect. Front Med (Lausanne), 10: 1128084. https://doi.org/10.3389/fmed.2023.1128084
Xu H, Tang RSY, Lam TYT, et al., 2023, Artificial Intelligence-Assisted Colonoscopy for Colorectal Cancer Screening: A Multicenter Randomized Controlled Trial. Clin Gastroenterol Hepatol, 21(2): 337–346.e3. https://doi.org/10.1016/j.cgh.2022.07.006
Jin P, Ji X, Kang W, et al., 2020, Artificial Intelligence in Gastric Cancer: A Systematic Review. J Cancer Res Clin Oncol, 146(9): 2339–2350. https://doi.org/10.1007/s00432-020-03304-9
Medina-Franco JL, 2021, Grand Challenges of Computer-Aided Drug Design: The Road Ahead. Front Drug Discov, 1: 728551. https://doi.org/10.3389/fddsv.2021.728551
Seo S, Lee JW, 2024, Applications of Big Data and AI-Driven Technologies in CADD (Computer-Aided Drug Design), in Gore M, Jagtap UB (Eds) Computational Drug Discovery and Design. Methods in Molecular Biology, vol 2714. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3441-7_16
Niu T, Zhang W, Zhao R, 2024, Solution-Oriented Agent-Based Models Generation with Verifier-Assisted Iterative In-Context Learning. arXiv, Preprint. https://doi.org/10.48550/arXiv.2402.02388
Hunsberger J, Simon C, Zylberberg C, et al., 2020, Improving Patient Outcomes with Regenerative Medicine: How the Regenerative Medicine Manufacturing Society Plans to Move the Needle Forward in Cell Manufacturing, Standards, 3D Bioprinting, Artificial Intelligence-Enabled Automation, Education, and Training. Stem Cells Transl Med, 9(7): 728–733. https://doi.org/10.1002/sctm.19-0389
Lwakatare LE, Raj A, Crnkovic I, et al., 2020, Large-Scale Machine Learning Systems in Real-World Industrial Settings: A Review of Challenges and Solutions. Inf Softw Technol, 127: 106368. https://doi.org/10.1016/j.infsof.2020.106368
Stalidzans E, Zanin M, Tieri P, et al., 2020, Mechanistic Modeling and Multiscale Applications for Precision Medicine: Theory and Practice. Netw Syst Med, 3(1): 36–56. https://doi.org/10.1089/nsm.2020.0002
Srinivasan M, Thangaraj SR, Ramasubramanian K, et al., 2023, Chapter 10 – Artificial Intelligence in Stem Cell Therapies and Organ Regeneration, in Sharma CP, Chandy T, Thomas V (Eds) Artificial Intelligence in Tissue and Organ Regeneration. Academic Press, Cambridge (MA), 175–190. https://doi.org/10.1016/B978-0-443-18498-7.00001-6
Takahashi T, Donahue RP, Nordberg RC, et al., 2023, Commercialization of Regenerative-Medicine Therapies. Nat Rev Bioeng, 1(12): 906–929. https://doi.org/10.1038/s44222-023-00095-9
Panuccio G, Subramaniyam NP, Canal-Alonso A, et al., 2024, Chapter 13 – Using AI to Steer Brain Regeneration: The Enhanced Regenerative Medicine Paradigm, in Carpentieri B, Lecca P (Eds) Big Data Analysis and Artificial Intelligence for Medical Sciences. John Wiley & Sons, Hoboken (NJ), 273–307. https://doi.org/10.1002/9781119846567.ch13
Rana M, Bhushan M, 2022, Machine Learning and Deep Learning Approach for Medical Image Analysis: Diagnosis to Detection. Multimed Tools Appl, 2022: 1–39. https://doi.org/10.1007/s11042-022-14305-w
Ngugi LC, Abelwahab M, Abo-Zahhad M, 2021, Recent Advances in Image Processing Techniques for Automated Leaf Pest and Disease Recognition – A Review. Inf Process Agric, 8(1): 27–51. https://doi.org/10.1016/j.inpa.2020.04.004
Dara S, Dhamercherla S, Jadav SS, et al., 2022, Machine Learning in Drug Discovery: A Review. Artif Intell Rev, 55(3): 1947–1999. https://doi.org/10.1007/s10462-021-10058-4
Udegbe FC, Ebulue OR, Ebulue CC, et al., 2024, Machine Learning in Drug Discovery: A Critical Review of Applications and Challenges. Computer Science & IT Research Journal, 5(4): 892–902. https://doi.org/10.51594/csitrj.v5i4.1048
Liao Y, Wang Y, Cheng M, et al., 2020, Weighted Gene Coexpression Network Analysis of Features That Control Cancer Stem Cells Reveals Prognostic Biomarkers in Lung Adenocarcinoma. Front Genet, 11: 311. https://doi.org/10.3389/fgene.2020.00311
Li Z, Zhang H, Wang X, et al., 2022, Identification of Cuproptosis-Related Subtypes, Characterization of Tumor Microenvironment Infiltration, and Development of A Prognosis Model in Breast Cancer. Front Immunol, 13: 996836. https://doi.org/10.3389/fimmu.2022.996836